These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35944844)

  • 1. Temporal and Sex-Linked Protein Expression Dynamics in a Familial Model of Alzheimer's Disease.
    Blasco Tavares Pereira Lopes F; Schlatzer D; Wang R; Li X; Feng E; Koyutürk M; Qi X; Chance MR
    Mol Cell Proteomics; 2022 Sep; 21(9):100280. PubMed ID: 35944844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
    J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
    Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
    Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.
    Youmans KL; Leung S; Zhang J; Maus E; Baysac K; Bu G; Vassar R; Yu C; LaDu MJ
    J Neurosci Methods; 2011 Mar; 196(1):51-9. PubMed ID: 21219931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Signaling of Dual-Specificity Phosphatase 4 (DUSP4) in Alzheimer's Disease.
    Wang E; Pan AL; Bagchi P; Rangaraju S; Seyfried NT; Ehrlich ME; Salton SR; Zhang B
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis.
    Bundy JL; Vied C; Badger C; Nowakowski RS
    J Comp Neurol; 2019 Feb; 527(2):462-475. PubMed ID: 30291623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.
    Eimer WA; Vassar R
    Mol Neurodegener; 2013 Jan; 8():2. PubMed ID: 23316765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.
    López-Gambero AJ; Rosell-Valle C; Medina-Vera D; Navarro JA; Vargas A; Rivera P; Sanjuan C; Rodríguez de Fonseca F; Suárez J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences between Neuronal Loss and the Early Onset of Amyloid Deposits and Behavioral Consequences in 5xFAD Transgenic Mouse as a Model for Alzheimer's Disease.
    Poon CH; Wong STN; Roy J; Wang Y; Chan HWH; Steinbusch H; Blokland A; Temel Y; Aquili L; Lim LW
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
    Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
    Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.